$RGBP Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program https://finance.yahoo.com/news/regen-biopharma-inc-receives-second-133000496.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance